Safety is paramount and at the forefront of every decision we make. Our automated manufacturing processes are designed in a manner where our treatments are not exposed to either the environment or our manufacturing staff. Additionally, we use ingredients and other inputs exclusively from U.S. FDA or EMA approved sources for all our sterile products.
Our innovation focused strategy has enabled us to launch over 15 first to market treatments across the countries we serve. The majority of our business stems from innovative products and we expect this strength will continue given our robust R&D pipeline that should double the number of first to market treatments across our portfolio by year end 2021.
The company was founded by Humza Naviwala in partnership with Ismail Industries in 2010. The company’s mission was to provide access to the latest generation treatments in an affordable manner from a manufacturing facility based in Karachi, Pakistan.
